Barclays
GHRS icon

Barclays’s GH Research GHRS Stock Holding History

Barclays’s Portfolio GHRS Stock Details GHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$61.8K Buy
4,394
+2,276
+107% +$34.9K ﹤0.01% 4234
2025
Q4 		$26.9K Buy
2,118
+822
+63% +$11.2K ﹤0.01% 4838
2025
Q3 		$18.5K Buy
+1,296
New +$18.1K ﹤0.01% 4951
2025
Q1 		– Sell
-1,703
Closed -$11.9K – 5362
2024
Q4 		$11.9K Sell
1,703
-4,281
-72% -$34.4K ﹤0.01% 4975
2024
Q3 		$40K Sell
5,984
-13,925
-70% -$143K ﹤0.01% 4793
2024
Q2 		$232K Sell
19,909
-11,591
-37% -$139K ﹤0.01% 3499
2024
Q1 		$336K Hold
31,500
– – ﹤0.01% 3830
2023
Q4 		$183K Sell
31,500
-32,090
-50% -$227K ﹤0.01% 4456
2023
Q3 		$639K Buy
63,590
+31,500
+98% +$364K ﹤0.01% 2640
2023
Q2 		$381K Hold
32,090
– – ﹤0.01% 2919
2023
Q1 		$256K Hold
32,090
– – ﹤0.01% 3659
2022
Q4 		$312K Hold
32,090
– – ﹤0.01% 3600
2022
Q3 		$373K Hold
32,090
– – ﹤0.01% 2862
2022
Q2 		$320K Sell
32,090
-2,002
-6% -$26K ﹤0.01% 3154
2022
Q1 		$624K Buy
+34,092
New +$602K ﹤0.01% 2738

Other funds holding GHRS

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
TCA
Troluce Capital Advisors Dorado, Puerto Rico $1.63B AUM 37.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Barclays's GHRS Position: Q1 2026 in Review

Barclays increased its GH Research (GHRS) stake by 107% in Q1 2026, buying an estimated $34.9K and bringing the position to 4,394 shares worth $61.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4234.

Barclays first reported a position in GHRS in Q1 2022 and has held it in 15 quarters since. The position peaked at $639K in Q3 2023. 54 funds tracked by Wall St. Rank hold GHRS as of Q1 2026.

  • Barclays held 4,394 shares of GH Research worth $61.8K as of Q1 2026.
  • Barclays bought 2,276 GH Research shares in Q1 2026, an estimated $34.9K.
  • GH Research made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4234 holding.
  • Barclays first reported a position in GH Research in Q1 2022 and has held it in 15 quarters since.
  • Barclays's GH Research position peaked at $639K in Q3 2023.
  • 54 funds tracked by Wall St. Rank held GH Research as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.